SKIP TO CONTENT
A two-day Conference brought together experts from the USA and Europe to discuss latest developments in the regulation of Biocides. The first day covered new developments in the US, including: “New Data Requirements for Antimicrobials (implementation of 158W),” “Efficacy Testing for Public Health Products,” “Testing – the Rise of Alternative Approaches,” and “Food Contact and Antimicrobials.”
Day two of the conference looked at global developments in the regulation of biocides. Countries and legislation covered included Canada, Europe the BPR, and Asia. The conference closed with a workshop covering the challenges of working in a global market and will include cross-comparisons between the European Union, the US and China.
The Acta Group’s Lisa. R. Burchi gave a presentation on Sept. 26th on “US Industry View of the BPR from First Years of Implementation” including first experiences with product authorization, clarifying treated articles status, active substance suppliers, data sharing and compensation challenges and comparison to FIFRA, and the status of guidance. Click here for more information.